Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
Browse
Conferences
Browse
< Back to conference highlights < Previous conference / Next conference >
Subscribe
Bookmark and Share

EHA 2019

13th - 16th Jun 2019

Videos

News

20.06.19

Chemotherapy-free strategies in treating leukaemia

20.06.19

Dasatinib-blinatumomab combination for the front-line...

20.06.19

Dose escalation of REGN1979 in patients with relapsed and...

20.06.19

ADMIRAL trial results: Gilteritinib versus salvage...

20.06.19

CD-19 mutation frequency after blinatumomab treatment is...

20.06.19

Multiple myeloma science from EHA 2019

20.06.19

CAR T-cell therapy for treating acute leukaemia

20.06.19

Selinexor plus cytarabine and idarubicin in patients with...

20.06.19

Controlling CRS-related coagulopathy improves the safety of...

20.06.19

ECHELON-1 study 3 year update: Frontline brentuximab vedotin...

20.06.19

ICARIA results: Treating RRMM patients with isatuximab,...

20.06.19

PET after 2 cycles of ABVD in patients with early-stage...

20.06.19

HORIZON update: Using melflufen to treat RRMM patients...

20.06.19

Safety and efficacy of escalating doses of Hu5F9-G4 with...

20.06.19

Combination of pegcrisantaspase and venetoclax in acute...

20.06.19

The changing landscape of AML

20.06.19

Using bioinformatics and genomics to treat AML

20.06.19

Blinatumomab for relapsed/refractory Burkitt's lymphoma

20.06.19

MOR208 plus lenalidomide in r-r diffuse large B-cell...

20.06.19

Chemoimmunotherapy or BTK inhibition for patients with CLL

20.06.19

CLL12 trial: Ibrutinib in previously untreated, asymptomatic...

20.06.19

CLL14: A chemotherapy-free regimen of venetoclax plus...

19.06.19

RESONATE-2: Five-year follow up of CLL patients receiving...

19.06.19

CD33 T cell recruiting antibody constructs for treatment of...

19.06.19

Targeted treatment of AML using T cell recruiting antibody...

15.06.19

Use of maintenance therapy following ASCT and real world...

15.06.19

Myeloma highlights from EHA 2019

15.06.19

Comment: Pregnancy outcomes in patients with chronic myeloid...

15.06.19

Comment: Fixed-duration venetoclax plus obinutuzumab in...

15.06.19

AlloHCT conditioning intensity in AML in complete remission...

15.06.19

ASCEND: Acalabrutinib versus rituximab with idelalisib or...

15.06.19

Inhibition of NADK strongly inhibits T-ALL cells from...

15.06.19

Novel immunotherapy 5F9 plus rituximab well tolerated with...

15.06.19

Acalabrutinib monotherapy shows significant benefit in...

15.06.19

Venetoclax with bortezomib and dexamethasone shows good...

14.06.19

D-VTd in induction prior to and consolidation after ASCT...

14.06.19

Imetelstat provides durable transfusion independence in...

14.06.19

Most pregnancies in CML patients resulted in normal...

14.06.19

Venetoclax plus obinutuzumab improves PFS and MRD-negativity...

14.06.19

Intervention for AML patients with MRD can result in...

Conferences Calendar

Information on upcoming conferences > find out where ecancer is filming next sign up for coverage submit your event

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation